HDP1:FRA
Arrowhead Pharmaceuticals Inc
€54.58
arrow_downward
-0.15%(-0.080) 1D
Nov 5, 8:10:02 AM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HDP1...
Open
€54.58
High
€54.58
Low
€54.58
Mkt. cap
8.71B
Avg. vol.
5.00
Volume
0.00
52-wk high
€80.72
52-wk low
€32.38
No. of employees
711
Open
€54.58
High
€54.58
Low
€54.58
Mkt. cap
8.71B
Avg. vol.
5.00
Volume
0.00
52-wk high
€80.72
52-wk low
€32.38
No. of employees
711
News stories
From web sources and news partners
BigGo Finance
·
24 minutes ago
Bitcoin Pulls Even With S&P 500 in Half of US Sessions, Glassnode Says
FXStreet
·
1 hour ago
Dow has best day since April 2025 as Brent drops 8.7% after Vance blames the Iran war
Reuters
·
57 minutes ago
S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
Yahoo Finance
·
55 minutes ago
Spdr Dow Jones Industrial Average ETF (DIA) Sells Goldman Sachs, Caterpillar on Nov. 3
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorBiotechnology
Industry-
Websitearrowheadpharma.com